#4-73E. Unveiling Systemic Disease: Alopecia as a Rheumatologic Marker (Best Pract Res Clin Rheumatol, 2026)

When a patient presents with sudden or unexplained hair loss in your daily practice, do you immediately consider looking beyond the scalp for signs of an underlying systemic disease? This episode reviews the intricate relationship between rheumatologic conditions and alopecia, comprehensively detailing how various immune, fibrotic, and microvascular mechanisms, alongside common pharmacologic therapies, can precipitate different subtypes of hair loss. The most crucial clinical takeaway from this research is that alopecia should not be dismissed as merely a cosmetic concern; rather, it serves as a vital, dynamic marker of underlying systemic inflammation and immune dysregulation, which can significantly aid in the early diagnosis of rheumatologic diseases. However, when critically appraising this evidence, it is important to note the current knowledge gaps: the exact prevalence and temporal onset of non-scarring hair loss in rheumatologic patients remain unclear, highlighting the need for further research. For physicians, understanding these shared pathogenic pathways is absolutely paramount. It encourages a highly structured diagnostic approach and fosters essential interdisciplinary collaboration between rheumatology and dermatology, ultimately facilitating earlier interventions to prevent irreversible follicular damage and dramatically optimize patient outcomes.

Citation: Burke L, Taylor KF. Alopecia across the spectrum of rheumatic disease. Best Practice & Research Clinical Rheumatology. 2026. DOI: 10.1016/j.berh.2026.1021631,8

Disclaimer: This audio summary is based on personal interpretation and does not guarantee the exact content of the original paper. Please refer to the original article for details.